Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,154.40
(
-0.67%
)
News Focus
News Focus
Post# of 824145
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

flipper44

Send PM Follow Ignore
Followers 309
Posts 37348
Boards Moderated 1
Alias Born 11/14/2013

flipper44

Member Level

Re: longfellow95 post# 223452

Thursday, 04/18/2019 5:02:56 PM

Thursday, April 18, 2019 5:02:56 PM

Post# of 824145
You've read the slide a million times. She states that for immunotherapy trials, endpoints may be different than for regular trials. Then she gives the example:

"Hazard ratio of long term survival versus one-year OS difference."

Respect Risk. Conduct Your Own Due Diligence. Manage your assets wisely. Diversify.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News